Емоклот (Human Coagulation Factor Viii)

Емоклот is a human coagulation factor VIII therapy for hemophilia A management. This intravenous treatment helps control and prevent bleeding episodes. It is manufactured by Kedrion S.P.A. and sourced from the EU. Buy human coagulation factor VIII online for hemophilia care.

Емоклот is used to treat and prevent bleeding in patients with hemophilia A, a genetic disorder causing insufficient clotting factor VIII. It may also be used perioperatively to reduce bleeding risk during surgical procedures. This therapy helps maintain normal blood clotting function in affected individuals. It is not indicated for von Willebrand disease or other clotting disorders.

Емоклот works by temporarily increasing factor VIII levels in the bloodstream, supporting normal clotting processes. Users may notice reduced frequency or severity of bleeding episodes after administration. The duration of effect depends on individual metabolism and dosing. Regular use helps maintain consistent protection against bleeding.

Store Емоклот refrigerated between 2°C and 8°C (36°F and 46°F) and protect from light. Do not freeze or shake the vial. Use only if the solution is clear and free of particles. Discard any unused portion after reconstitution. Keep out of reach of children and pets. Consult a healthcare provider before use if pregnant, breastfeeding, or planning surgery.

Емоклот may interact with other clotting factor products or medications affecting blood clotting. Avoid combining with anticoagulants like warfarin unless directed by a doctor. Alcohol and certain herbal supplements (e.g., ginkgo biloba) may increase bleeding risk. Always inform your healthcare provider about all medications and supplements in use.